Stonepine Capital Management as of June 30, 2016
Portfolio Holdings for Stonepine Capital Management
Stonepine Capital Management holds 23 positions in its portfolio as reported in the June 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| SciClone Pharmaceuticals | 14.5 | $14M | 1.1M | 13.06 | |
| Viveve Medical | 10.9 | $11M | 2.6M | 4.10 | |
| Aegerion Pharmaceuticals 2% Du cvbond | 10.1 | $9.9M | 17M | 0.57 | |
| Vanda Pharmaceuticals (VNDA) | 9.3 | $9.1M | 812k | 11.19 | |
| Tobira Therapeutics Inc Common Stock Usd 0.0001 | 8.2 | $8.0M | 638k | 12.56 | |
| Pain Therapeutics | 6.4 | $6.2M | 2.8M | 2.19 | |
| Qlt | 5.5 | $5.4M | 3.8M | 1.42 | |
| Sagent Pharmaceuticals | 5.5 | $5.3M | 356k | 14.98 | |
| Vericel (VCEL) | 5.2 | $5.1M | 2.3M | 2.25 | |
| Cutera | 5.0 | $4.9M | 438k | 11.21 | |
| Recro Pharma | 3.5 | $3.4M | 429k | 7.95 | |
| Alere | 3.2 | $3.1M | 75k | 41.68 | |
| Sucampo Pharmaceuticals | 2.4 | $2.3M | 214k | 10.97 | |
| Pacira Pharmaceuticals (PCRX) | 1.8 | $1.8M | 52k | 33.73 | |
| Flamel Technologies | 1.4 | $1.4M | 128k | 10.74 | |
| Pernix Therapeutics Holdings | 1.4 | $1.4M | 6.0M | 0.23 | |
| BioSpecifics Technologies | 1.2 | $1.2M | 30k | 39.93 | |
| Enanta Pharmaceuticals | 1.2 | $1.2M | 53k | 22.05 | |
| Derma Sciences | 1.1 | $1.1M | 283k | 3.94 | |
| Veracyte (VCYT) | 1.0 | $940k | 187k | 5.03 | |
| Cumberland Pharmaceuticals (CPIX) | 0.6 | $580k | 129k | 4.50 | |
| Aviragen Therapeutics | 0.4 | $412k | 294k | 1.40 | |
| DURECT Corporation | 0.1 | $98k | 80k | 1.22 |
